This is a non-blinded, non-randomized controlled pilot study with no follow-up. Patients will be recruited from the coronary angiography patient pool of the American Hospital of Paris and assigned to one of 2 groups in a non-randomized manner.
This is a non-blinded, non-randomized controlled pilot study with patients who will be followed during their coronary angiography procedure and with no follow-up. Patients will be recruited from the coronary angiography patient pool of the American Hospital of Paris and assigned to one of 2 groups in a non-randomized manner. It is expected to enroll around 100 patients and this is estimated to be obtained in a period of 2 months approximately. Patients will be placed in the control group, without music intervention, or assigned to the music group. Assignment will be done in this manner due to limited availability of the hardware and software to the investigation team. Patients in both groups will be matched based on age, sex, weight, height, American Society of Anesthesiology (ASA) score, and prior medical history, including diabetes, hypertension, chronic kidney disease and stroke. Each patient will receive a standardized sedation in the traditional manner and at the discretion of the investigator to reach Bispectral index (BIS) score below 90 and sedation score ≤ 1. The primary study end points will be the consumptions in analgesics and hypnotics. Secondary study end points will be pain and anxiety scores as measured the Numeric Rating Scale (NRS), the Visual Analog Scale (VAS) and the Amsterdam Preoperative Anxiety and Information Scale (APAIS).
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
76
The intervention group will administer "U" sequence between 10 minutes prior to the beginning of the procedure until its end.
American Hospital of Paris
Neuilly-sur-Seine, France
Dose Use of Midazolam Medication (mg)
The consumption in Midazolam medication was reported during the coronary angioplasty. Dose was in mg.
Time frame: Between 10 minutes prior to the beginning of the procedure up to 45 minutes.
Dose Use of Propofol Medication (mg)
The consumption in Propofol medication was reported during the coronary angioplasty. Dose was in mg.
Time frame: Between 10 minutes prior to the beginning of the procedure up to 45 minutes.
Dose Use of Sufentanil Medication (ug)
The consumption in Sufentanil medication was reported during the coronary angioplasty. Dose was in ug.
Time frame: Between 10 minutes prior to the beginning of the procedure up to 45 minutes.
Pain Score
Pain score was measured using the Visual Analog Scale (VAS). This scale ranged from 0 (no pain) to 10 (very high pain), and collected the maximum pain the patient had during the procedure. This was collected right after the end of the procedure in the recovery room.
Time frame: From 0 up to 45 minutes.
Anxiety Score (NRS)
Anxiety score was measured using the Numeric Rating Scale (NRS). This scale ranged from 0 (no anxiety) to 10 (very high anxiety), and collected the maximum anxiety the patient had during the procedure. This was collected right after the end of the procedure in the recovery room.
Time frame: From 0 up to 45 minutes.
Satisfaction of the Patient
Satisfaction was measured using a scale from 0 to 5, with a higher score for a high satisfaction.
Time frame: Right after the end of the procedure in the recovery room.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Effect on Physiological Parameters: BIS
Bispectral index (BIS) score at baseline which corresponds to 10 minutes before the beginning of the procedure. The BIS monitor provides a single dimensionless number which ranges from 0 (equivalent to EEG silence) to 100. Higher is the score, better it is.
Time frame: 10 minutes prior to the beginning of the procedure
Effect on Physiological Parameters: Heart Rate
Heart rate at Baseline which corresponds to 10 minutes before the beginning of the procedure.
Time frame: 10 minutes prior to the beginning of the procedure.
Effect on Physiological Parameters: SpO2%
SpO2 at Baseline which corresponds to 10 minutes before the beginning of the procedure..
Time frame: 10 minutes prior to the beginning of the procedure.
Effect on Physiological Parameters: Mean Arterial Blood Pressure
Mean arterial blood pressure at Baseline which corresponds to 10 minutes before the beginning of the procedure.
Time frame: 10 minutes prior to the beginning of the procedure.